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Introduction: Septic shock is one of the most frequent causes of admission to the intensive care unit (ICU) and is
associated with a poor prognosis. Early and late death in septic shock should be distinguished because they may
involve different underlying mechanisms. In various conditions, the neutrophil-to-lymphocyte count ratio (NLCR) has
been described as an easily measurable parameter to express injury severity. In the present study, we investigated
whether the timing of death was related to a particular NLCR.
Methods: We conducted a prospective, single-center, observational study that included consecutive septic shock
patients. Severity scores, early (before day 5) or late (on or after day 5 of septic shock onset) ICU mortality, and daily
leukocyte counts were collected during the ICU stay. We assessed the association between leukocyte counts at
admission and their evolution during the first 5 days with early or late death. The association between patient
characteristics (including cell counts) and prognosis was estimated using Cox proportional cause-specific hazards models.
Results: The study included 130 patients who were diagnosed with abdominal (n = 99) or extra-abdominal (n = 31)
septic shock. The median (interquartile range) NLCR was 12.5 (6.5–21.2) in survivors and 6.2 (3.7–12.6) in nonsurvivors
(p = 0.001). The NLCR at admission was significantly lower in patients who died before day 5 than in survivors (5 [3.5–
11.6] versus 12.5 [6.5–21.2], respectively; p = 0.01). From day 1 to day 5, an increased NLCR related to an increase in
neutrophil count and a decrease in lymphocyte count was associated with late death (+34.8 % [−8.2 to 305.4] versus
−20 % [−57.4 to 45.9]; p = 0.003). Those results were present in patients with abdominal origin sepsis as well as in those
with extra-abdominal sepsis, who were analyzed separately.
Conclusions: In the present study, a reversed NLCR evolution was observed according to the timing of death. Septic
shock patients at risk of early death had a low NLCR at admission, although late death was associated with an
increased NLCR during the first 5 days.Introduction
Although the rate has been reduced by compliance with
the bundles recommended by the Surviving Sepsis Cam-
paign, reported septic shock mortality still varies from
29 % to 38 % [1]. Both pro- and anti-inflammatory re-
sponses occur early and simultaneously in septic shock.
A rapid and early upregulation of genes of the innate* Correspondence: florence.riche@aphp.fr
1Département d’Anesthésie - Réanimation - SMUR, Hôpitaux Universitaires
Saint Louis – Lariboisière, Paris, France
2UFR de Médecine, Université Paris Diderot, Paris, France
Full list of author information is available at the end of the article
© 2015 Riché et al. Open Access This article i
International License (http://creativecommons
reproduction in any medium, provided you g
the Creative Commons license, and indicate if
(http://creativecommons.org/publicdomain/zeimmune response occurs, along with downregulation of
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acute dysregulation may result in death in the first week
(“early death”). This initial dysregulation may evolve to a
complex state combined with an unabated innate im-
mune response, which can lead to persistent, nonresol-
ving inflammation, resulting in organ dysfunction and
an impaired adaptive immune response that leaves the
host unable to react to any assault [5–7]. This other type
of dysregulation may lead to death within or beyond the
first month (“late death”). In addition, several studies have
suggested an even longer–term mortality due to sepsis
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early (before day 5) and late (after day 5) death is increas-
ingly being studied and may involve different underlying
mechanisms [11–17]. Patients who die quickly must be
taken into account in any study of sepsis and must not be
excluded, because they represent a sizable ratio and are
distinguished from those who may die after a longer
period of time [18].
Polymorphonuclear neutrophils are the first cellular
defense against infection and the key cell type of the in-
nate immune system. The response to bacterial infection
involves neutrophil recruitment and extravasation into
the infected tissues. It can be seen as equilibrium be-
tween bone marrow release and tissue migration [19].
Lymphocytes are heterogeneous cell populations with
different functional and phenotypical properties involved
in adaptive immunity. Lymphopenia has been proposed
as an indicator of mortality in severe sepsis, mainly be-
cause of its activation of apoptotic processes [20–22].
The physiological immune response of circulating leuko-
cytes to various stressful events is often characterized by
an increase in neutrophil counts and a decline in lympho-
cyte counts. Zahorec demonstrated a correlation between
the severity of the clinical course and the grade of neu-
trophilia and lymphocytopenia [23]. He proposed the
neutrophil-to-lymphocyte count ratio (NLCR), which is
an easily measurable parameter to express injury severity.
In the context of infections, the NLCR has been proven to
predict bacteremia more accurately than routine parame-
ters [24]. Using administrative data, researchers in a recent
study suggested that the NLCR is associated with 28-day
mortality in unselected intensive care unit (ICU) patients;
however, they did not find this association when they fo-
cused on patients with sepsis [25]. Moreover, it seems that
there is some association between the source of the infec-
tion and hospital mortality in patients with septic shock.
Leligdowicz et al. [26] indicated that sepsis originating
from the abdomen was associated with the highest
rate of hospital mortality and that obstructive uropathy-
associated urinary tract infections were associated with
the lowest rate.
Accordingly, in the present study, we investigated
whether the timing of death was related to a particular
NLCR. In addition, we compared a group of patients
with septic shock originating from the abdomen with a
group who had sepsis of extra-abdominal origin.
Methods
Study design and ethical approval
We conducted a single-center prospective study in a sur-
gical ICU. The protocol was approved by the institu-
tional review board at our center (Comité d’Evaluation
de l’Ethique des projets de Recherche Biomédicale Paris
Nord, IRB 0006477).Patient selection
All consecutive patients with septic shock of abdominal
or extra-abdominal origin admitted to the ICU from
January 2011 to January 2014 were enrolled. All patients
were admitted for septic shock, and data collection was
started within 12 h of the onset of shock. Septic shock
was defined according to the criteria of the American
College of Chest Physicians/Society of Critical Care
Medicine consensus conference [27]. Patients younger
than 18 years of age, pregnant patients, and patients
with aplasia or immunosuppressive disease (e.g., HIV) or
receiving immunosuppressive therapy (chemotherapy,
chronic used of steroids, autoimmune disease treatment)
were excluded from the study. Of note, no patients re-
ceived steroids during their ICU stay. All included pa-
tients were informed about the study and consented to
participate. If the patient was unable to be informed, the
next of kin was informed and provided consent for the
patient to participate.
Outcome measure
The main outcome measure was ICU mortality, which
was categorized as early death (death from day 1 to day 4)
or late death (death on or after day 5).
Data collection
The following demographic and clinical data were col-
lected: age, sex, comorbidities (Charlson comorbidity
index score) [28], Simplified Acute Physiology Score II,
Sequential Organ Failure Assessment score at day 1,
length of ICU stay, ICU mortality, and associated second-
ary infections [29]. Circulating neutrophil and lymphocyte
counts and the NLCR were determined at ICU admission
and daily until discharge or death. When this count was
performed several times per day, only the first measure-
ment was considered. The normal ranges for the leukocyte
counts in our central laboratory were 1.8–7 × 109/L for
neutrophils, 1–4 × 109/L for lymphocytes, and NLCR = 2
(range, 0.45–7). Moreover, variations in cell counts and
the NLCR from day 1 to day 5 were studied. Variations
were defined as the relative difference in values between
day 5 and day 1 (100 × [day 5 − day 1]/day 1).
Statistical analysis
Continuous variables were expressed as the median (inter-
quartile range), and categorical variables were expressed
as the count (percentage). Patient characteristics were
compared among several groups, namely survivors and
early and late mortality, using the Kruskal-Wallis test (for
continuous variables when more than two groups were
compared), the Wilcoxon test (for continuous variables
when two groups were compared), and the χ2 test (in all
other cases). The main endpoint of the study was to inves-
tigate the association between the NLCR and ICU
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ICU admission to time of death or discharge). The cumu-
lative incidence of ICU mortality over time was estimated,
and alive at discharge was considering as a competing
event. Associations between patient characteristics (in-
cluding cell counts) and prognosis were estimated using
Cox proportional cause-specific hazards models. Appro-
priate methods to analyze the censored data were used.
The ability of cell counts to discriminate survivors from
nonsurvivors was studied using receiver operating charac-
teristic (ROC) curves and areas under the ROC curve
(AUC). Statistical analyses were performed using R
statistical software (http://www.r-project.org/). A two-
sided p value <0.05 was considered statistically significant.
Results
Table 1 shows the baseline characteristics of the cohort
of 130 septic shock patients. Septic shock that originated




(n = 99) (1)
Age, yr 72.7 (60.3–82.4) 72.5 (6
Female 54 (41.5) 42 (4
Male 76 (58.5) 57 (5
Origin of sepsis
Digestive tract 99 (74.6) 99 (1
Bone and soft tissue 14 (11) 0 (0
Pulmonary 7 (5) 0 (0
Urinary tract 6 (4) 0 (0
Blood/endocarditis 4 (3) 0 (0
Comorbidities
CAD 24 (18) 20 (2
Diabetes 28 (21) 23 (2
COPD 13 (10) 8 (8
Cancer/immunosuppression 33 (25) 28 (2
Charlson comorbidity index score 5 (4–6) 5 (4
Severity and outcome
SAPS II 52.5 (42–60.8) 52 (4
SOFA score at admission 8 (6–12) 8 (6
In-ICU LOS 5 (2–11.8) 5 (2
In-ICU mortality 54 (41.5) 37 (3
Hospital-acquired infection 29 (22.3) 20 (2
Cell counts at admission
Neutrophils, 109/L 9.7 (4–16.3) 10.1 (3
Lymphocytes, 109/L 0.8 (0.5–1.3) 0.8 (0
NLCR 9.3 (4.8–18.2) 9 (4
Abbreviations: CAD coronary artery disease, COPD chronic obstructive pulmonary dis
Failure Assessment, ICU intensive care unit, LOS length of stay, NLCR neutrophil-to-l
Continuous variables are expressed as median with interquartile range or count witthe 130 patients, 117 (90 %) benefited from bacteriological
sampling from the nidus of infection and 22 (17 %) of
those presented with bacteremia at admission. Of the
sample, 22 % were sterile, and multiple microorganisms
were found in 8 %. Gram-negative bacilli were identified
in 47 % of the cases, gram-positive cocci in 34 %, and
yeast in 8 %. Overall, ICU mortality was 41 % (54 of 130
patients), with 61 % (33 of 54) of the deaths occurring dur-
ing the first 4 days (the “early-death group”) and 39 % (21
of 54) occurring on or after day 5 (the “late-death group”)
(Fig. 1).
Admission circulating neutrophil and lymphocyte counts
and NLCRs of survivors versus nonsurvivors
Considering the cohort of 130 patients, the neutrophil
count at admission was similar between survivors and
nonsurvivors. The lymphocyte count was higher (p =
0.002) with a reduced NLCR (p = 0.0014) in the nonsurvi-
vor group (Table 2). Differentiation of early and late deathseptic shock Extra-abdominal septic shock
(n = 31) (2)
p Value (1) vs (2)
1.4–82) 74 (58.7–84.2) 0.76
2.4) 12 (38.7) 0.54






0) 4 (13) 0.36
3) 5 (16) 0.4
) 5 (16) 0.19
8) 5 (16) 0.17
–6) 5 (4–6) 0.86
0.5–61) 53 (44–59) 0.61
–11.5) 9 (8–12) 0.066
–10) 10 (3–18) 0.061
7.4) 17 (54.8) 0.085
0.2) 9 (29) 0.3
.9–16.3) 8.3 (5.8–17.1) 0.78
.5–1.3) 0.9 (0.6–1.4) 0.88
.6–17.9) 11.5 (5.5–18.5) 0.47
ease, SAPS II Simplified Acute Physiology Score II, SOFA Sequential Organ
ymphocyte count ratio
h percentage, as appropriate
Fig. 1 Flowchart depicting the study process. ICU intensive care unit








Age, yr 70.7 (57.9–81.7) 75.7 (64.6–83.3) 0.095
Female 31 (40.8) 23 (42.6) 0.84
Male 45 (59.2) 31 (57.4)
Comorbidities
CAD 14 (18.4) 10 (18.5) 0.99
Diabetes 16 (21.1) 12 (22.2) 0.87
COPD 8 (10.5) 5 (9.3) 0.81
Cancer/
immunosuppression
19 (25) 14 (25.9) 0.9
Charlson comorbidity
index score
5 (3–6) 5 (4–6.8) 0.052
Severity and outcome
SAPS II 44 (39.8–54) 59.5 (53–70) <0.0001
SOFA score at admission 7 (5.8–9) 12 (7–14.8) <0.0001
In-ICU LOS 7 (4–11.2) 3 (1.2–11.8) 0.0049
Hospital-acquired
infection
12 (15.8) 17 (31.5) 0.034
Cell counts at admission
Neutrophils, 109/L 9.7 (5.5–16.5) 9.8 (3.2–16.2) 0.43
Lymphocytes, 109/L 0.7 (0.5–1.1) 1.1 (0.7–1.9) 0.0022
NLCR 12.5 (6.5–21.2) 6.2 (3.7–12.6) 0.0014
Abbreviations: CAD coronary artery disease, COPD chronic obstructive
pulmonary disease, SAPS II Simplified Acute Physiology Score II, SOFA
Sequential Organ Failure Assessment, ICU intensive care unit, LOS length of
stay, NLCR neutrophil-to-lymphocyte count ratio
Continuous variables are expressed as median with interquartile range or
count with percentage, as appropriate
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was significantly lower than that of both late-death pa-
tients and survivors (p = 0.01) (Table 3). Of note, the
NLCR was higher in patients with bacteremia at admis-
sion (13.9 [9.1 to 31.2] versus 8.8 [4.6 to 16.4]; p = 0.024).
Circulating neutrophils, lymphocytes, and NLCR variations
from admission to day 5 in survivor and late-death groups
Among the patients alive at day 5, patients who died later
(late-death group) were compared with survivors. At day
5, 70 patients were alive, and 21 of those subsequently
died. In the late-death group, the variations in the circulat-
ing neutrophil and lymphocyte counts from day 1 to day 5
were compared with those of survivors. The neutrophil in-
crease (difference between day 5 and day 1) was significant
(p = 0.026), with a decreased lymphocyte count (p = 0.034)
and a subsequent increase in the NLCR (p = 0.003) associ-
ated with the risk of late death (Table 4). The daily values
for cell counts from day 1 to day 5 are shown in Fig. 2 and
Additional file 1: Table S1.
Discriminatory threshold of early and late death
The discriminatory ability of neutrophils, lymphocytes,
and the NLCR to predict early or late death is shown in
Fig. 3. The AUCs for NLCRs were 0.7, 0.65, and 0.72 for
overall, early death, and late death, respectively. The
most accurate discriminatory NLCR thresholds were 7.7
(sensitivity = 0.71, specificity = 0.61) for overall mortality,
5.3 (sensitivity = 0.78, specificity = 0.55) for early death,
and an increase of 18 % in the NLCR for late death (see
Additional file 2: Table S2).
Of note, these results were present both in patients
with sepsis of abdominal origin and in those with extra-
abdominal sepsis, who were analyzed separately (see
Additional file 3: Table S3 and Additional file 4: Figures S4
and S5).
Table 3 Patient characteristics according to survivors, early death, and late death
Survivors (n = 76) (1) Early death (n = 33) (2) Late death (n = 21) (3) p Value (2) vs (1 + 3) p Value (2) vs (3)
Age, yr 70.7 (57.9–81.7) 74.7 (65–81.9) 77.9 (64.4–85.7) 0.57 0.38
Female 31 (40.8) 14 (42.4) 9 (42.9) 0.9 0.97
Male 45 (59.2) 19 (57.6) 12 (57.1) 0.97
Comorbidities
CAD 14 (18.4) 7 (21.2) 3 (14.3) 0.64 0.51
Diabetes 16 (21.1) 5 (15.2) 7 (33.3) 0.30 0.12
COPD 8 (10.5) 3 (9.1) 2 (9.5) 0.84 0.96
Cancer/immunosuppression 19 (25) 8 (24.2) 6 (28.6) 0.86 0.73
Charlson comorbidity index score 5 (3–6) 5 (4–6) 5 (4–7) 0.15 0.97
Severity and outcome
SAPS II 44 (39.8–54) 64 (56–76) 55 (49–61) <0.0001 0.003
SOFA score at admission 7 (5.8–9) 13 (10–16) 8 (6–9) <0.0001 0.0004
In-ICU LOS 7 (4–11.2) 2 (1–2) 14 (10–22) <0.0001 <0.0001
Hospital-acquired infection 12 (15.8) 3 (9.1) 14 (66.7) 0.035 <0.0001
Cell counts at admission
Neutrophils, 109/L 9.7 (5.5–16.5) 6.9 (2.5–16.3) 10.9 (6.1–13.2) 0.15 0.25
Lymphocytes, 109/L 0.7 (0.5–1.1) 0.9 (0.6–1.6) 1.2 (0.9–2) 0.35 0.17
NLCR 12.5 (6.5–21.2) 5 (3.5–11.6) 7 (4–12.9) 0.011 0.41
Abbreviations: CAD coronary artery disease, COPD chronic obstructive pulmonary disease, SAPS II Simplified Acute Physiology Score II, SOFA Sequential Organ
Failure Assessment, ICU intensive care unit, LOS length of stay, NLCR neutrophil-to-lymphocyte count ratio
Continuous variables are expressed as median with interquartile range or count with percentage, as appropriate
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In the present study, we found that at the onset of septic
shock, a low NLCR was associated with nonsurvival.
This low NLCR was due to a higher lymphocyte count.
When distinguishing time until death in the early-death
(before day 5) and late-death (on or after day 5) groups,
the NLCR of the early-death patients at admission was
significantly lower than that of late-death patients and
survivors. The risk of late death was associated with a
neutrophil increase, lymphocyte count decrease, and
subsequent increase in the NLCR from day 1 to day 5.
Early death (before day 5) versus late death (on or after
day 5) is increasingly being studied [5, 6, 11, 14–17]. An
overly strong immune response with a cytokine storm [2],
mitochondriopathy, and massive tissue damage may lead
to early death [3]. This dysregulation may cause a complex
state combining an unabated innate immune response
that leads to persistent inflammation, resulting organ dys-
function, and an impaired adaptive immune response that
leaves the host unable to react to any assault [2, 6]. In our
study, clinical characteristics did not differ between early-
and late-death patients, particularly age, severity scores,
and comorbidities. The most remarkable clinical differ-
ence was that of hospital-acquired infections, which was
2.7 times higher in nonsurvivors. Although nonsignificant,
the ICU length of stay was longer in nonsurvivors.Whether the hospital-acquired infection was a consequence
of alteration of adaptive function related to lymphopenia,
whether it was responsible for neutrophilia, or both re-
mains unclear.
Most of the prognostic scores mention leukocytosis
(>12,000/mm3) or leukopenia (<4000/mm3) as a severity
index, but none considers the leukocyte subpopulations
[30–34]. Significant differences between neutrophil and
lymphocyte counts and, consequently, their ratio have
been shown to predict the severity or outcome in differ-
ent pathological circumstances, such as surgical stress,
systemic inflammation and sepsis [23], bacteremia [24],
community-acquired pneumonia [35], ischemic events
[36], and cancer [37, 38]. We must be cautious because
the prognostic value of the NLCR in our study is below
the value of 0.8 that is felt to be indicative of a reliable
prognostic marker.
The evolution of these leukocyte populations may dif-
fer based on their respective role in the inflammatory re-
sponse. Neutrophils are the first cellular line of defense
in the innate immune system and have a short half-life,
while lymphocytes are the major cells of the adaptive
immune system.
In our study, all patients were lymphopenic. Lympho-
penia is due first to a huge recruitment from peripheral
circulation to the nidus of infection, followed by
Table 4 Neutrophil, lymphocyte, and NLCR variations from admission to day 5 in late survivors and late nonsurvivors
Survivors after day 5 (n = 49) Late death after day 5 (n = 21) p Value
Age, yr 72.5 (61.6–79.3) 77.9 (64.4–85.7) 0.2
Female 16 (32.7) 9 (42.9) 0.41
Male 33 (67.3) 12 (57.1)
Comorbidities
CAD 12 (24.5) 3 (14.3) 0.34
Diabetes 11 (22.4) 7 (33.3) 0.34
COPD 7 (14.3) 2 (9.5) 0.59
Cancer/immunosuppression 10 (20.4) 6 (28.6) 0.46
Charlson comorbidity index score 5 (3–6) 5 (4–7) 0.66
Severity and outcome
SAPS II 48 (42–56) 55 (49–61) 0.083
SOFA score at admission 9 (6–10) 8 (6–9) 0.58
In-ICU LOS 10 (7–18) 14 (10–22) 0.15
Hospital-acquired infection 12 (24.5) 14 (66.7) 0.00082
Cell counts at admission
Neutrophils, 109/L 8.2 (5.5–16.1) 10.9 (6.1–13.2) 0.68
Lymphocytes, 109/L 0.7 (0.5–1.1) 1.2 (0.9–2) 0.0012
NLCR 11.8 (6.6–18.3) 7 (4–12.9) 0.06
Cell counts at day 5
Neutrophils, 109/L 9.2 (6.7–11.8) 16.4 (13.3–24.2) 0.0001
Lymphocytes, 109/L 1 (0.8–1.3) 1 (0.7–1.3) 0.89
NLCR 9.1 (6.7–12.5) 12.8 (8.4–35.4) 0.028
Cell counts variations from day 1 to day 5
Neutrophils, % 6.3 (−47.2 to 75.3) 50.5 (3.4 to 207.0) 0.026
Lymphocytes, % 33.3 (−20.0 to 141.7) −21.8 (−43.2 to 44.6) 0.034
NLCR, % −20.0 (−57.4 to 45.9) 34.8 (−8.2 to 305.4) 0.003
Abbreviations: CAD coronary artery disease, COPD chronic obstructive pulmonary disease, SAPS II Simplified Acute Physiology Score II, SOFA Sequential Organ
Failure Assessment, ICU intensive care unit, LOS length of stay, NLCR neutrophil-to-lymphocyte count ratio
Riché et al. Critical Care  (2015) 19:439 Page 6 of 10lymphocyte apoptosis caused by several stimuli [20]; per-
sistent lymphopenia of the late-death patients is most
likely due to ongoing sepsis-induced lymphocyte apop-
tosis secondary to the continued release of proapoptotic
stimuli and the nonresolution of inflammation.
Among the patients with lymphopenia, the lympho-
cyte count was higher in all nonsurvivors than in survi-
vors. This difference was not found when all
nonsurvivors were separated into early- and late-death
groups, probably because of the small number of pa-
tients in each group. Nevertheless, the NLCR was sur-
prisingly reduced in patients who died early,
independent of the origin of the sepsis. This result
might be explained by a decrease in neutrophils associ-
ated with an increased lymphocyte count. Some re-
searchers have not reported this result, likely because
they included only patients who survived until day 4
hospital mortality without considering death in the first5 days [18]. Accounting for death in the first 5 days is a
significant issue. In the present study, more than two-
thirds of the patients died in the first 5 days, which is a
high rate and cannot be ignored. Although lymphocyte
apoptosis is well described in septic shock, some au-
thors have demonstrated that the early phase of human
sepsis is characterized by a combination of apoptosis
and the proliferation of T cells. A rapid recovery of total,
CD4+, and CD8+ T lymphocytes could indicate their in-
tense trafficking between tissues and the lymphatic sys-
tem during the acute phase of illness [12, 39–42].
Moreover, patients who die early might produce higher
levels of stress hormones such as adrenaline, which in-
creases lymphocyte counts [43]. Although the exact
underlying mechanism for a higher lymphocyte count in
nonsurvivors remains unclear and requires further in-
vestigation, the NLCR appears to be a simple parameter
to detect patients at risk of early death.
Fig. 2 Daily values of circulating neutrophils, lymphocytes, and neutrophil-to-lymphocyte count ratio (NLCR) from day 1 to day 5. Shaded bars repre-
sent nonsurvivors; open bars indicate survivors. p Values derived from two-way analysis of variance are reported in Additional file 1: Table S1. The box
depict median value (thick bar) with 25the 75th, 10th and 90th percentiles
Riché et al. Critical Care  (2015) 19:439 Page 7 of 10An increase in the NLCR from day 1 to day 5, with an
increase in the neutrophil count and a smooth drop in
the lymphocyte count, was associated with late death in
our study population. Interestingly, in other studiesresearchers have found that late mortality, at 6 months
or 12 months after emergency abdominal surgery, was
associated with a persistent high neutrophil count [44].
Increased neutrophils might indicate that the site of the
Fig. 3 Receiver operating characteristic curves for the best neutrophil-to-lymphocyte count ratio (NLCR) thresholds to predict overall mortality (a),
early death (b), and late death (c). Areas under the curve with 95 % confidence intervals are displayed in Additional file 2: Table S2
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pus or abscess in the peritoneal cavity or other nidus.
Thus, the bone marrow continues to produce large
amounts of neutrophils to fight the infection. We also
suggest that the neutrophils might not become apop-
totic. In contrast to lymphocytes, neutrophil apoptosis is
beneficial in sepsis. The apoptosis of these cells initiates
and facilitates the resolution of inflammation, tissue
repair, and reestablishment of homeostasis. Apoptotic neu-
trophils are cleared by macrophages and prompt the
macrophages to switch from a proinflammatory to an anti-
inflammatory phenotype [21, 45, 46]. This neutrophilic
pattern could reflect a nonresolving inflammation [47].
Finally, while some studies have indicated that the
source of infection is important to consider because the
immune response differs according to the site [26], we
did not find any significant differences between the ab-
dominal and extra-abdominal sepsis groups concerning
lymphocytes, neutrophil counts, or the NLCR in the
early- or late-death groups. However, the size of the
extra-abdominal sepsis group was quite small compared
with the abdominal sepsis group.
Limitations of the study
The present study has several limitations. First, we con-
ducted a single-center observational study, and thus, as
with any observational study, the potential remains for re-
sidual confounding. The results have to be confirmed in
other centers. Second, for some patients, several measures
were available on the same day, and we always used the
first one to maximize to consistency among the patients.
However, we could have missed information related to
intraday cell count variations. Third, we analyzed circulating
neutrophil and lymphocyte counts and did not explore
the different subsets of lymphocytes. Phenotypic markers
are missing, but this is the subject of a forthcoming study.
Fourth, our sample size was limited, and our results
should be confirmed in a larger population. Given ourlimited sample size, we were not able to study other time
points to define late death, such as death after 14 days or
28 days. Finally, no information about inflammatory bio-
markers (such as C-reactive protein or procalcitonin) was
available in our patients; the role of these markers in this
context and their potential interaction with NLCR should
be assessed.
Conclusions
This study demonstrates a clear relationship between
the NLCR and the risk of death in septic shock patients.
A reversed NLCR evolution was observed according to
the timing of death. Septic shock patients at risk of early
death presented a low NLCR at admission, although late
death was associated with an increased NLCR during
the first 5 days. Early and late death should be distin-
guished because they may involve different underlying
mechanisms, and the NLCR might be considered as a
discriminant indicator of early or late death.
In addition, our findings provide more insight into biol-
ogy. The circulating neutrophil and lymphocyte trends ob-
served in this study offer an interesting mechanistic
viewpoint. We observed that circulating lymphocytes and
the NLCR behave in opposite ways in early- and late-
death patients, supporting the hypothesis that divergent
mechanisms could be involved in these two groups.
Key messages
 In patients admitted to the ICU for septic shock, a
low NLCR at admission is associated with a risk of
early death.
 In the same population, an increase in the NLCR
during the first 5 days is associated with a risk of
late death.
 Early and late death should be distinguished
because they may involve different underlying
mechanisms.
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